Automated External Defibrillator Market Size and Share

Automated External Defibrillator Market Analysis by Mordor Intelligence
The Automated External Defibrillator Market size is estimated at USD 1.76 billion in 2026, and is expected to reach USD 2.52 billion by 2031, at a CAGR of 7.44% during the forecast period (2026-2031).
Rising public-access programs, integration with smart-city platforms and expanding corporate ESG mandates are narrowing the life-saving gap between collapse and first shock. Vendors amplify demand by bundling training, consumables and cloud software into subscription contracts, which convert large cash purchases into manageable operating fees. Regulators on both sides of the Atlantic now favor biphasic, impedance-compensated waveforms, a shift that pushes hospitals and emergency medical services to replace older monophasic devices. Supply-chain reforms under the EU Battery Directive and U.S. reshoring policies reconfigure lithium sourcing, yet they also incentivize higher-density batteries that extend service intervals. Competitive intensity grows as connected-device start-ups and Chinese manufacturers vie with entrenched multinationals for hospital, workplace and community accounts.
Key Report Takeaways
- By product type, semi-automatic units held 58.24% of automated external defibrillator market share in 2025, whereas fully-automatic devices are forecast to expand at a 9.78% CAGR through 2031.
- By technology, biphasic waveform platforms commanded 91.11% share of the automated external defibrillator market size in 2025 and will progress at a 9.45% CAGR during the forecast window.
- By modality, professional-use models accounted for 61.73% revenue share in 2025, while public-access devices are projected to grow 10.25% annually to 2031.
- By end user, hospitals and clinics captured 58.34% share of the automated external defibrillator market size in 2025, yet public-access locations are advancing at a 10.64% CAGR.
- By geography, North America led with 44.22% revenue share in 2025; Asia-Pacific is poised for the fastest 9.34% regional CAGR through 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Automated External Defibrillator Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising incidence of sudden cardiac arrest (SCA) | 1.8% | Global, with acute burden in North America, Europe and urbanizing Asia-Pacific | Long term (≥ 4 years) |
| Government-funded Public Access Defibrillation (PAD) programs | 2.1% | North America & EU lead; APAC core (China, Japan, India) accelerating; spill-over to MEA | Medium term (2-4 years) |
| Technological shift to biphasic & impedance-compensated waveforms | 1.2% | Global, with regulatory emphasis in FDA and EU MDR jurisdictions | Medium term (2-4 years) |
| Integration of AEDs into smart-city IoT emergency networks | 0.9% | APAC core (China, South Korea), North America pilot cities, EU smart-city initiatives | Long term (≥ 4 years) |
| Corporate ESG mandates adding AED coverage to workplace HSE KPIs | 0.8% | North America & EU multinational headquarters; expanding to APAC subsidiaries | Short term (≤ 2 years) |
| Subscription-based "AED-as-a-Service" lowering CAPEX barriers | 0.6% | National, with early gains in United States, United Kingdom, Australia | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Rising Incidence of Sudden Cardiac Arrest (SCA)
Out-of-hospital SCA reached 350,000 U.S. events annually, and survival drops roughly 10% with every minute’s delay to defibrillation.[1]Samya Madhukar and Gina Peattie, “Latest Statistics,” Sudden Cardiac Arrest Foundation, sca-aware.org New American Heart Association 2025 guidelines shorten recommended response intervals and broaden pediatric protocols, prompting higher device densities in schools and sports venues.[2]American Heart Association, “2025 American Heart Association Guidelines for CPR and ECC,” American Heart Association, cpr.heart.orgMunicipal planners now map four-minute walk radii for AED placement, while during the CPR Awareness Week, India's Ministry of Health engaged over 747,000 citizens, providing physical training to more than 606,374 participants nationwide.[3]Press Information Bureau Staff, “Pan-India CPR Awareness Week Organized by Ministry of Health and Family Welfare to Strengthen Community Response Capacity,” Press Information Bureau, pib.gov.in Aging populations intensify baseline risk in Japan and Europe, but middle-income Asia-Pacific nations record the steepest absolute growth because lifestyle diseases are outpacing emergency-response build-outs.
Government-Funded Public-Access Defibrillation (PAD) Programs
China installed more than 64,000 public-access units in 2024, and Beijing committed to 2,000 networked cabinets with GPS telemetry. The United Kingdom set aside GBP 1 million (USD 1.27 million) in 2025 to place 2,000 devices in underserved areas. U.S. jurisdictions such as New York City and New Hampshire translate policy into bulk-buy contracts that quote Philips HeartStart OnSite at USD 898.79 and ZOLL AED Plus at USD 1,070. European decrees in France, Germany and Italy similarly mandate defibrillators in public buildings, creating predictable replacement cycles.
Technological Shift to Biphasic & Impedance-Compensated Waveforms
Biphasic shocks deliver higher first-shock success and less myocardial injury than legacy monophasic energy, an advantage embedded in FDA 510(k) clearances. ZOLL’s rectilinear biphasic waveform, validated in trials of 11,500 patients, underpins the AED 3 and AED Plus lines. Stryker’s LIFEPAK CR2 analyses rhythm during compressions, while Philips and Nihon Kohden add real-time impedance adjustment. Regulators harmonize dossiers under EU MDR, accelerating global rollouts and driving a replacement wave away from monophasic stock.
Integration into Smart-City IoT Emergency Networks
Daily self-test telemetry from Nihon Kohden’s Cardiolife AED-3100 flows via Bluetooth to cloud dashboards, alerting managers to expiring pads. ZOLL’s PlusTrac software links Wi-Fi equipped AED 3 units to dispatch centers, and Beijing pilots route the nearest trained bystander through WeChat when a 911-equivalent call falls within 300 meters of a registered cabinet. South Korea’s Emergency Medical Service Act encourages similar telemetry ties to its national 119 system. These integrations cut median time-to-shock by two to three minutes in early studies, justifying higher upfront device costs.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High acquisition & maintenance cost for small institutions | -0.9% | Global, acute in rural North America, emerging APAC, MEA, South America | Medium term (2-4 years) |
| Limited reimbursement & liability concerns in emerging markets | -0.7% | APAC emerging (India, Indonesia, Philippines), MEA, South America | Long term (≥ 4 years) |
| Supply-chain dependence on lithium cells facing EU/US sourcing rules | -0.5% | Global, with regulatory pressure in EU (Battery Directive) and US (IRA, CHIPS Act reshoring) | Short term (≤ 2 years) |
| End-of-life environmental compliance (battery & pad waste) | -0.3% | EU (WEEE Directive), California, select APAC jurisdictions (Japan, South Korea) | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
High Acquisition & Maintenance Cost for Small Institutions
A basic AED sells for USD 849-1,795, but five-year ownership doubles after pad, battery, cabinet and training expenses. Small nonprofits often depend on donated, non-connected devices, leaving one in five units unusable when needed. Grants exist yet administrative burdens deter the smallest clinics and volunteer fire departments, perpetuating geographic inequity.
Limited Reimbursement & Liability Concerns in Emerging Markets
National insurance schemes in India and Indonesia do not reimburse AED purchases, and Good Samaritan protections remain untested in courts, suppressing bystander willingness to intervene. China’s installations vary by province, and insurance carriers in many emerging markets exclude AED-related claims, forcing institutions to self-insure.
Segment Analysis
By Product Type: Semi-Automatic Dominance Yields to Full-Auto Simplicity
Semi-automatic units controlled 58.24% automated external defibrillator market share in 2025, reflecting decades of training that tells rescuers to press a button only after confirming safety. Fully-automatic devices will compound at 9.78% through 2031 as public venues prefer hardware that fires without hesitation. ZOLL’s AED 3 and Stryker’s LIFEPAK CR2 come in both modes, letting buyers match user profiles. Airports and stadiums lean toward full-auto for untrained crowds, whereas hospitals still favor semi-auto for clinical oversight. Pricing parity—it often costs less than USD 100 to switch modes—removes cost as a barrier, leaving policies and confidence to steer adoption.
Fully-automatic gains feed the automated external defibrillator market by shortening pause time, which studies link to higher return-of-spontaneous-circulation rates. Regulatory frameworks in Japan and South Korea allow both modes, though their training curricula still echo semi-auto norms, slowing transition. As more public-access networks go live, familiarity with hands-free operation should accelerate replacement demand for semi-auto stock, nudging the automated external defibrillator industry toward simplicity.

By Technology: Biphasic Waveforms Cement Preference
Biphasic platforms captured 91.11% share of automated external defibrillator market size in 2025 and will rise 9.45% annually. FDA registrants now use biphasic comparators for substantial equivalence, effectively making monophasic filings obsolete. ZOLL’s rectilinear waveform adjusts energy to patient impedance, while Stryker’s cprINSIGHT analyzes rhythm without stopping compressions, removing one to two minutes of idle time per case.
Monophasic devices linger in older hospital inventories and low-income markets, but Chinese exporters are also adopting biphasic designs, cutting price gaps and speeding global phase-out. These advances align with studies showing higher first-shock efficacy and lower tissue damage, guaranteeing that future automated external defibrillator market replacements gravitate to biphasic hardware.
By Modality: Public-Access Surge Challenges Professional-Use Incumbency
Professional-use models owned 61.73% of revenue in 2025 because hospitals and EMS fleets value manual overrides and ECG integration. Yet public-access units are set to outgrow them at 10.25% CAGR as municipalities, schools and corporations follow updated building codes. China’s Red Cross placed 64,000 devices in 2024, and the U.K. funded another 2,000 for underserved areas, adding momentum.
Public-access buyers seek three-step voice-prompt simplicity, multilingual support and Wi-Fi self-tests, all while keeping prices between USD 849 and USD 1,795. EMS agencies will still buy rugged units with IP55 housing and longer-life batteries, but the volume story for the automated external defibrillator market clearly tilts toward public venues.

By End User: Public Access Locations Outpace Hospital Incumbents
Hospitals and clinics held 58.34% share in 2025, anchored by mandatory crash-cart stocking and data-system integration. Public-access sites, however, are expanding fastest at 10.64% CAGR, driven by building mandates and liability mitigation at sports arenas, transit hubs and office towers. New York City’s Local Law 20 and France’s Decree 2018-1186 crystallize these obligations.
Emergency medical services equip transport-grade models that survive temperature extremes, while home-care uptake remains low because consumer units still exceed USD 1,000. Venture-backed platforms like Avive aim to lower thresholds with connected home devices and subscription monitoring, foreshadowing another wave of automated external defibrillator market growth once payers and regulators catch up.
Geography Analysis
North America contributed 44.22% of 2025 revenue thanks to mature public-access legislation in all 50 U.S. states and federal grants under the Rural Access to Emergency Devices Act. New American Heart Association guidelines published in 2025 adjust device specs for schools and childcare centers. Canada and Mexico trail the U.S. in per-capita deployment but offer catch-up opportunity as provinces and private employers fund new placements.
Asia-Pacific is on track for the fastest 9.34% regional CAGR through 2031. China’s Red Cross installed 64,000 devices in 2024 and Beijing ordered 2,000 smart cabinets with live GPS feeds. Japan’s Fire and Disaster Management Agency continues to push devices into public facilities, and South Korea’s EMS Act requires units in schools and large commercial buildings. India’s annual CPR Awareness Week trains 100,000 citizens, yet federal AED mandates and liability clarity remain pending, limiting immediate conversion.
Europe balances moderate growth with stringent environmental rules. The United Kingdom has earmarked GBP 1 million for community placements, and France, Germany and Italy enforce location-specific mandates. The EU Battery and WEEE Directives raise compliance costs but also motivate upgrades to longer-life batteries and pad recycling programs. Middle East-Africa and South America remain nascent, although GCC nations and Brazil’s metro health secretariats are piloting public-access programs that could scale on positive survival data.

Competitive Landscape
The top five suppliers, ZOLL Medical, Stryker, Bridgefield-owned Philips Emergency Care, Cardiac Science, and Nihon Kohden, together control more than half of the revenue, giving the automated external defibrillator market a moderate level of concentration. ZOLL monetizes Real CPR Help and See-Thru algorithms at premium prices in EMS and hospital channels, while Stryker’s LIFEPAK CR2 targets buyers seeking minimal pause time. Philips’ January 2025 divestiture signals a pivot away from hardware, inviting rivals and Chinese entrants such as Mindray to chase freed share.
IoT-centric challengers intensify rivalry. Avive raised USD 56.5 million in 2024 to commercialize cloud-connected devices that stream event data directly to 911 dispatch. Distributors like Safe Life, valued at EUR 500 million by Bridgepoint in 2025, aggregate multibrand offerings and overlay compliance software, capturing margin via service rather than hardware.
White-space opportunities include home-use devices and full-stack program-management platforms that bundle training, consumables and telemetry into recurring subscriptions. Regulatory harmonization under EU MDR and streamlined FDA 510(k) pathways lower barriers for newcomers, while smart-city pilots normalize Wi-Fi and cellular connectivity, shifting competition from hardware specs to data ecosystems and service quality.
Automated External Defibrillator Industry Leaders
Stryker Corporation
Nihon Kohden Corporation
Koninklijke Philips NV
Asahi Kasei (ZOLL Medical)
Shenzhen Mindray Bio-Medical
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- November 2025: A Duke Health–led consortium began a Forsyth County, North Carolina, clinical trial dispatching AED-carrying drones during real 911 calls.
- October 2025: Defibtech endorsed U.S. House Bill 5897, aiming to mandate AEDs in interstate transportation facilities.
- October 2025: The Superior Fire Department installed SaveStation kiosks with outdoor AEDs at Barker’s Island and Loon’s Foot Landing, funded through a community grant.
- June 2025: Rotary Club of Bombay Airport and Schiller India completed the 50th AED installation across Mumbai railway stations using the FRED PA-1 model.
Research Methodology Framework and Report Scope
Market Definitions and Key Coverage
Our study defines the automated external defibrillator (AED) market as all portable, microprocessor-controlled devices that analyze cardiac rhythm and, when needed, deliver a pre-programmed electric shock to restore normal rhythm in out-of-hospital or in-facility sudden cardiac arrest events. The sizing covers new semi-automated and fully-automated units sold through institutional and commercial channels, plus software and disposables bundled at first sale, for 2019-2030.
Scope exclusion: Implantable cardioverter defibrillators, wearable cardioverter defibrillators, and standalone manual external defibrillators are outside this analysis.
Segmentation Overview
- By Product Type
- Semi-Automatic AEDs
- Fully-Automatic AEDs
- By Technology
- Biphasic Waveform AEDs
- Monophasic Waveform AEDs
- By Modality
- Professional-Use AEDs
- Public-Access AEDs
- By End User
- Hospitals & Clinics
- Emergency Medical Services (EMS)
- Public Access Locations
- Home Care
- Others (Training Institutions, Corporate Wellness)
- By Geography
- North America
- United States
- Canada
- Mexico
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
- South America
- Brazil
- Argentina
- Rest of South America
- North America
Detailed Research Methodology and Data Validation
Primary Research
Multiple touchpoints with cardiologists, biomedical engineers, hospital buyers, EMS chiefs, and facility safety managers across North America, Europe, Asia-Pacific, and the Gulf validated volume trends, average selling prices, regulatory lead-times, and replacement cycles. These interviews helped refine assumption ranges and resolve conflicting desk findings before we locked the model.
Desk Research
Mordor analysts first mapped the addressable pool using authoritative, non-paywalled sources such as the World Health Organization's sudden cardiac arrest incidence tables, American Heart Association out-of-hospital arrest survival registries, U.S. FDA MAUDE alerts on device recalls, and national EMS databases that publish public-access AED density. Trade associations (for example, the Sudden Cardiac Arrest Foundation and the European Resuscitation Council) offered data on installation mandates and training penetration. Company 10-Ks, investor decks, customs statistics from UN Comtrade on electrode pads and lithium batteries, and D&B Hoovers financial snapshots supplied cost and shipment clues. This list is illustrative; many other public and paid inputs were reviewed to cross-check figures and narrative.
Market-Sizing & Forecasting
A top-down prevalence-to-demand model begins with age-band sudden cardiac arrest incidence, multiplies by mandated public-access coverage ratios, and is reconstructed through import-export plus production data. Results are then challenged with sampled bottom-up roll-ups of leading supplier shipments and channel checks. Key variables include AED penetration in schools and airports, average selling price drift by connectivity level, battery life-driven replacement cadence, and year-on-year shifts in CPR-trained population. Forecasts use exponential smoothing blended with scenario analysis; coefficients are stress-tested in workshops with clinical experts. Where bottom-up gaps surface, for example, in Latin America, regional averages are imputed from correlated incidence and GDP-per-capita bands and later replaced when fresh primary data arrives.
Data Validation & Update Cycle
Outputs pass a multi-analyst variance review, anomaly flags prompt source re-verification, and any delta beyond three percent triggers a re-interview loop. Reports refresh annually; interim events such as new national legislation or major recalls activate an unscheduled update so clients receive our latest viewpoint.
Why Mordor's Automated External Defibrillator Market Baseline Earns Decision-Makers' Confidence
Published estimates often differ because firms choose dissimilar product scopes, assumption sets, and refresh cadences.
Key gap drivers include whether implantable and wearable devices are mixed with AEDs, the aggressiveness of unit-price erosion curves, and how swiftly regulatory wins are baked into volume ramps. Mordor's model isolates only automated externals, applies country-specific price curves validated every six months, and revises the base year at each annual refresh, which curbs over or under shoot risk.
Benchmark comparison
| Market Size | Anonymized source | Primary gap driver |
|---|---|---|
| USD 1.73 B (2025) | Mordor Intelligence | - |
| USD 1.84 B (2024) | Global Consultancy A | Includes wearable and manual devices in scope |
| USD 1.51 B (2024) | Industry Journal B | Uses list-price erosion at 3 % p.a. without country splits |
In sum, the disciplined scoping, variable-level validation, and yearly recalibration executed by Mordor Intelligence give clients a balanced, transparent baseline they can trace back to clear assumptions and repeatable steps, reducing decision uncertainty.
Key Questions Answered in the Report
What is the current value of the automated external defibrillator market?
The market is valued at USD 1.76 billion in 2026 and is forecast to reach USD 2.52 billion by 2031.
How fast is demand for public-access AEDs growing?
Public-access units are projected to expand at a robust 10.25% CAGR through 2031, outpacing professional-use devices.
Which technology dominates new AED approvals?
Biphasic, impedance-compensated waveforms account for more than 90% of 2025 sales and remain the regulatory preference.
Why are subscription models becoming popular?
AED-as-a-Service spreads device, consumables and training costs into predictable annual fees, easing budgets for schools and small businesses.
Which region offers the fastest growth potential?
Asia-Pacific leads with a projected 9.34% CAGR as China, Japan and India scale national public-access programs.
What challenges limit wider deployment in emerging markets?
High upfront costs, limited reimbursement and uncertain Good Samaritan liability protections hamper adoption despite rising cardiac-arrest incidence.




